Ensoma
Prior to Ensoma, Chapman Wright served as director of process development at Generation Bio, where he guided the development of the company’s novel drug substance production platform. There, his responsibilities included material generation for "in vitro/in vivo" preclinical studies, upstream and downstream process development, and management of CMO operations.
This person is not in the org chart
Ensoma
1 followers
Ensoma believes every person, no matter where they are, should have access to innovative technologies that are changing the way we treat disease. Harnessing the power of their Engenious™ vectors, their therapies can be delivered in a simple, single injection.